| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/28/2004 | US6797696 Contacting a bodily fluid with an antibody which binds to an human aspartyl (asparaginyl) beta-hydroxylase (haah) polypeptide to form a complex and detecting the complex; treating malignant neoplasms by inhibiting haah. |
| 09/28/2004 | US6797692 Use of glutamate antagonists for the treatment of cancer |
| 09/28/2004 | US6797504 For prevention and treatment of cancer, tumors, metastasis; drug screening |
| 09/28/2004 | US6797502 Polypeptide for use in the treatment of hypertriglyceridemia, atherosclerosis and eating disorders |
| 09/28/2004 | US6797499 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 09/28/2004 | US6797491 Human papilloma virus treatment |
| 09/28/2004 | US6797489 PP14 fusion proteins and methods for making and using the same |
| 09/28/2004 | US6797281 Esters of I-carnitine or alkanoyl I-carnitines |
| 09/28/2004 | CA2292359C Novel azalides and methods of making same |
| 09/28/2004 | CA2167268C Anti-angiogenic compositions and methods of use |
| 09/23/2004 | WO2004081190A2 Uses of il-23 agonists and antagonists; related reagents |
| 09/23/2004 | WO2004081050A1 Antibody against tumor specific antigen as target |
| 09/23/2004 | WO2004081027A2 Neoplasm specific antibodies and uses thereof |
| 09/23/2004 | WO2004080973A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors |
| 09/23/2004 | WO2004080933A2 Isolation of lutein from alfalfa |
| 09/23/2004 | WO2004080922A2 Substituted vitamin d analogues and their therapeutic uses |
| 09/23/2004 | WO2004080486A1 Tumorigenesis inhibitor |
| 09/23/2004 | WO2004080485A1 Preventive/remedy for diseases in upper digestive tract |
| 09/23/2004 | WO2004080479A1 Gonadal function improving agents |
| 09/23/2004 | WO2004080477A1 Aplidine for multiple myeloma treatment |
| 09/23/2004 | WO2004080474A1 Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising prenyl flavonoids |
| 09/23/2004 | WO2004080464A1 Use of isoquinoline derivatives for treating cancer and map kinase related diseases |
| 09/23/2004 | WO2004080462A1 c-Kit KINASE INHIBITOR |
| 09/23/2004 | WO2004080460A1 SUBSTITUTED PIPERIDINES AS NOVEL MDM2-p53 INHIBITORS |
| 09/23/2004 | WO2004080455A1 Antibacterial agent and anticancer agent |
| 09/23/2004 | WO2004080445A1 Methods and compositions for the treatment of cancer |
| 09/23/2004 | WO2004080425A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080423A2 7-amino- isoindolyl compounds amd their pharmaceutical uses |
| 09/23/2004 | WO2004080421A2 Improved antitumoral treatments |
| 09/23/2004 | WO2004080418A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080398A2 1-amino 1h-imidazoquinolines |
| 09/23/2004 | WO2004080379A2 Extract of pangium edule and lignanes which can be used as a cathepsin inhibitor or having an antinecrotic effect |
| 09/23/2004 | WO2004080271A2 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof |
| 09/23/2004 | WO2004072027A3 Chemical derivatives binding very specifically with g-quadruplex dna structures and use thereof as a specific anti-cancer agent |
| 09/23/2004 | WO2004038006A3 Purine nucleosides |
| 09/23/2004 | WO2004014293A3 Combination of anti-muscarinic agents and non-glucocorticoid steroids |
| 09/23/2004 | WO2004010947A3 Humanized antibodies against human 4-1bb |
| 09/23/2004 | WO2003106621A3 Anti-igf-i receptor antibody |
| 09/23/2004 | WO2003094836A3 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 09/23/2004 | WO2003086175A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/23/2004 | WO2003082268A3 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 09/23/2004 | WO2003068809A8 An herpes simplex virus complex |
| 09/23/2004 | WO2003046204A3 Humanized collagen antibodies and related methods |
| 09/23/2004 | WO2003011219A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 09/23/2004 | US20040186299 such as 3-(3,5-dimethoxyphenyl)-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)-phenoxy]-phenyl}-acrylic acid; for lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes; for increasing leptin levels with no liver toxicity |
| 09/23/2004 | US20040186288 3,5-Diamino-1,2,4-triazoles as kinase inhibitors |
| 09/23/2004 | US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/23/2004 | US20040186175 Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 09/23/2004 | US20040186161 Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/23/2004 | US20040186157 inhibiting kinases; for treating or preventing neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, AIDS dementia |
| 09/23/2004 | US20040186156 useful for solid tumors and leukemia; auto-immune diseases such as psoriasis, alopecia and multiple sclerosis; cardiovascular diseases such as stenoses, arterioscleroses and restenoses; infectious diseases caused by unicellular parasites; nephrological diseases, neurodegenerative diseases |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 09/23/2004 | US20040186129 2-Aroylimidazole compounds for treating cancer |
| 09/23/2004 | US20040186127 E.g., 7-(5-(2-(cyclohexylmethylamino)ethyl)indol-2-yl), 2-methyl-3H-imidazo(4,5-b)pyridine; antiinflammatory agents; antiproliferative agents; autoimmune diseases; reperfusion injuries; osteoporosis; bone disorders; antimetastasis agents |
| 09/23/2004 | US20040186126 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/23/2004 | US20040186118 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 09/23/2004 | US20040186110 Nitrogenous heterocylic compounds |
| 09/23/2004 | US20040186106 such as (S)-N-{{(1R, 2R)-2-{4-{[2-(4-Methyl-piperazin-1-yl)-benzimidazol-1-yl]methyl}-phenyl}-cyclohex-1-yl} carbonyl}-phenylglycinamide; for treatment of ischemic brain disorders |
| 09/23/2004 | US20040186101 such as 6-(3-Chlorophenyl)-4,4-dimethyl-1,4-dihydrobenzo[d][1,3]oxazin-2-one; hormone replacement therapy |
| 09/23/2004 | US20040186099 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 09/23/2004 | US20040186095 Harringtonine and homoharringtonine are cephalotaxane drugs; natural or synthetic products from plant extracts; pure crystals; treating leukemia, tumors, parasitic disease, or as immunosuppressant, antitumor agents |
| 09/23/2004 | US20040186088 Mercapto-cycloalkyl or heterocyclyl ring-sulfonyl-aryl or heteroaryl derivatives; preventing the cleavage Of tumor necrosis factor- alpha from cell membranes in mammal; treating autoimmune diseases, inflammation, inflammatory bowel disease, Crohn's disease, asthma, sepsis and septic shock |
| 09/23/2004 | US20040186051 Apo-2 ligand variants and uses thereof |
| 09/23/2004 | US20040186045 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/23/2004 | US20040185563 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 09/23/2004 | US20040185510 Administering a composition sufficient for external imaging, a peptide of given formula; radioactive scanning or by magnetic resonance; use for detecting metastasis; kits |
| 09/23/2004 | US20040185508 Methods and reagents for modulating cholesterol levels |
| 09/23/2004 | US20040185507 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 09/23/2004 | US20040185489 Gene transcription assay method |
| 09/23/2004 | US20040185485 Gene markers useful for detecting skin damage in response to ultraviolet radiation |
| 09/23/2004 | US20040185439 using polymorphisms to determine susceptibility cancer, osteoporosis, cardiovascular disorders; for drug screening |
| 09/23/2004 | US20040185122 Selective COX-2 inhibition from edible plant extracts |
| 09/23/2004 | US20040185117 Cephalotaxine alkaloid compositions and uses thereof |
| 09/23/2004 | US20040185113 Sparingly water-soluble calcium-containing inorganic microparticles and a drug or biodrug encapsulated therein; made by adding a calcium compound to a solution of a carbonate, phosphate, oxalate or urate and the drug to form the calcium salt of the carbonate, phosphate, oxalate or urate |
| 09/23/2004 | US20040185058 Immunogenic polypeptides physically linked; anticarcinogenic, antitumor, antiallergen, and viricidal agents; autoimmune diseases; systemic or mucosal vaccines; genetic engineering |
| 09/23/2004 | US20040185057 Therapeutical vaccination |
| 09/23/2004 | US20040185053 Comprising targeting and chemotherapeutic moieties linked via thiol group; anticarcinogenic and antitumor agents; autoimmune disease and infection treatment |
| 09/23/2004 | US20040185052 Antitumor agents; leukemia; |
| 09/23/2004 | US20040185048 Modulation of IL-2- and IL-15-mediated T cell responses |
| 09/23/2004 | US20040185033 Tumor antigens and CTL clones isolated by a novel procedure |
| 09/23/2004 | US20040184990 Receptor binding conjugates |
| 09/23/2004 | DE10307104A1 Antitumor wirksame 2-substituierte Estra-1,3,5(10)-trien-3-yl sulfamate Antitumor effective 2-substituted estra-1,3,5 (10) -triene-3-yl sulfamates |
| 09/23/2004 | DE10303254B3 3,3-Dimethyl-8-oxoisochinoline, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zusammensetzungen und deren Verwendung 3,3-dimethyl-8-oxoisochinoline, processes for their preparation, pharmaceutical compositions containing them and their use |
| 09/23/2004 | CA2801100A1 Novel antibacterial agents |
| 09/23/2004 | CA2518912A1 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | CA2518898A1 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | CA2518787A1 Antibody against tumor specific antigen as target |
| 09/23/2004 | CA2518748A1 Antimicrobial agents and anticancer agents |
| 09/23/2004 | CA2518584A1 7-amino- isoindolyl compounds and their pharmaceutical uses |
| 09/23/2004 | CA2518541A1 Gonadal function improving agents |
| 09/23/2004 | CA2518531A1 2-substituted vitamin d analogues and their therapeutic uses |
| 09/23/2004 | CA2518530A1 Use of isoquinoline derivatives for treating cancer and map kinase related diseases |
| 09/23/2004 | CA2518262A1 Uses of il-23 agonists and antagonists; related reagents |
| 09/23/2004 | CA2517885A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors |
| 09/23/2004 | CA2517655A1 1-amino 1h-imidazoquinolines |
| 09/23/2004 | CA2516572A1 Improved antitumoral treatments |
| 09/23/2004 | CA2516145A1 Substituted piperidines as novel mdm2-p53 inhibitors |
| 09/22/2004 | EP1460072A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/22/2004 | EP1460067A1 Bicyclic derivative, process for producing the same, and use |